Literature DB >> 7033895

Immunoprecipitation of biosynthetically-labelled proteins from different Papua New Guinea Plasmodium falciparum isolates by sera from individuals in the endemic area.

G V Brown, R F Anders, J D Stace, M P Alpers, G F Mitchell.   

Abstract

The human serum antibody response to Plasmodium falciparum infection in Papua New Guinea has been studied by electrophoretic analysis of immunoprecipitated biosynthetically-labelled malaria proteins from three different isolates maintained in long-term in vitro culture. Differences in protein antigenic composition in different lines have been described and simplified by examination of antigens recognized only by hyperimmune serum. An in vitro assay has been used to screen various human sera containing antimalarial antibody for their ability to inhibit parasite growth and the immunoprecipitation profiles of non-inhibitory sera have been compared with those of a hyperimmune serum pool. In the discussion, emphasis is placed on the value of immunoprecipitation analyses using clinically-defined sera with known in vitro function in the identification of antigens which may be responsible for the induction of host-protective immunity.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7033895     DOI: 10.1111/j.1365-3024.1981.tb00407.x

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  9 in total

1.  Differential effect of immunoglobulin on the in vitro growth of several isolates of Plasmodium falciparum.

Authors:  G V Brown; R F Anders; G Knowles
Journal:  Infect Immun       Date:  1983-03       Impact factor: 3.441

2.  Plasmodium falciparum: protein antigens identified by analysis of serum samples from vaccinated Aotus monkeys.

Authors:  S C Kan; K M Yamaga; K J Kramer; S E Case; W A Siddiqui
Journal:  Infect Immun       Date:  1984-01       Impact factor: 3.441

3.  Proteins with molecular masses of 25 to 40 kilodaltons elicit optimal protective responses against Plasmodium chabaudi adami infection.

Authors:  P E Kima; I K Srivastava; C A Long
Journal:  Infect Immun       Date:  1992-12       Impact factor: 3.441

4.  Identification of two integral membrane proteins of Plasmodium falciparum.

Authors:  J A Smythe; R L Coppel; G V Brown; R Ramasamy; D J Kemp; R F Anders
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

5.  Cooperation between antibodies and monocytes that inhibit in vitro proliferation of Plasmodium falciparum.

Authors:  S Khusmith; P Druilhe
Journal:  Infect Immun       Date:  1983-07       Impact factor: 3.441

6.  Association between human serum-induced crisis forms in cultured Plasmodium falciparum and clinical immunity to malaria in Sudan.

Authors:  J B Jensen; M T Boland; J S Allan; J M Carlin; J A Vande Waa; A A Divo; M A Akood
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

7.  Expression of Plasmodium falciparum blood-stage antigens in Escherichia coli: detection with antibodies from immune humans.

Authors:  D J Kemp; R L Coppel; A F Cowman; R B Saint; G V Brown; R F Anders
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

8.  Surface alterations of erythrocytes in Plasmodium falciparum malaria. Antigenic variation, antigenic diversity, and the role of the spleen.

Authors:  M Hommel; P H David; L D Oligino
Journal:  J Exp Med       Date:  1983-04-01       Impact factor: 14.307

9.  Antibodies in malarial sera to parasite antigens in the membrane of erythrocytes infected with early asexual stages of Plasmodium falciparum.

Authors:  H Perlmann; K Berzins; M Wahlgren; J Carlsson; A Björkman; M E Patarroyo; P Perlmann
Journal:  J Exp Med       Date:  1984-06-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.